Aspirin could help obesity-related liver disease
The common aspirin could help people suffering from obesity-related liver disease, according to a new study.
Research by Yale University found that during testing on mice, aspirin reduced receptors which can activate liver inflammation.
It also reduced mortality caused by an overdose of acetaminophen.
Wajahat Mehal, from the university’s section of digestive diseases and department of immunobiology, said the results suggest "aspirin may help prevent and treat liver damage from a host of non-infectious causes".
He added these would include side effects from drugs, alcohol abuse and obesity-related illnesses.
Mr Mehal stated: "Our strategy is to use aspirin on a daily basis to prevent liver injury."
"This offers the exciting possibility of reducing a lot of pain and suffering in patients with liver diseases, using a new and very practical approach."
Anti-obesity pill Alli recently went on sale across Britain without a prescription for the first time.
The drug will be available over-the-counter after European watchdogs gave it the go-ahead.
The Insurance Helpline specialises in obtaining cover for people living with obesity
Leave a Reply